# Jamie Dimon

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/jamie-dimon
Canonical HTML page: https://gethealthbrief.com/entity/jamie-dimon

## Timeline

- **2026-04-14**: JPM Q1 Earnings Report — JPMorgan Chase reports first-quarter financial results amidst regulatory and legal scrutiny.
- **2026-04-10**: FDA Orforglipron Decision — Expected regulatory ruling on Eli Lilly's oral GLP-1 candidate for weight loss.

## Recent coverage (1 stories)

### April Catalysts: Eli Lilly’s Oral GLP-1 Decision and JPM Earnings Outlook
2026-03-23 00:14:25 · Sentiment: Positive · Impact: 7/10 · Sources: 5

Investors are monitoring two critical mid-April deadlines: the FDA's decision on Eli Lilly's oral weight-loss drug, orforglipron, and JPMorgan Chase's first-quarter earnings report. These events serve as key indicators for the pharmaceutical sector's obesity market expansion and the banking sector's regulatory resilience.
Full story: https://gethealthbrief.com/story/eli-lilly-jpmorgan-april-catalysts-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.